Discover 1,567 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: East Brunswick NJ, Lebanon NH, Brampton, Fort Wayne IN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07155187
Phase2, Phase3, Recruiting
Featured
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
for
Breast Cancer
Location: East Brunswick NJ, Jacksonville FL, Kansas City MO,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07368998
Phase2, Recruiting
Featured
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
for
HER2-positive Breast Cancer
Location: East Brunswick NJ, Shirley NY, Albany NY, Montreal,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07413939
Phase2, Phase3, Recruiting
Featured
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for
Neovascular Age-related Macular Degeneration
Location: Little Silver NJ, Philadelphia PA, Towson MD,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07007065
Phase3, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Paterson NJ, The Bronx NY, Valhalla NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
for
Cancer Risk
Location: Totowa NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 18+
Code: NCT06804395
Recruiting
Active & Responsive
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Location: Clifton NJ, Boston MA, Richmond VA, Cleveland OH,
Sponsor: Palette Life Sciences, Inc.
Sex: Male
Age: 18+
Code: NCT06496256
Recruiting
Active & Responsive
LRG GIST Patient Registry
for
GIST, GIST - Gastrointestinal Stromal Tumor,
Location: Wayne NJ
Sponsor: The Life Raft Group
Sex: All
Age: 0+
Code: NCT07697248
Recruiting
Active & Responsive
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
for
Arthritis, Rheumatoid
Location: Midland Park NJ, Summit NJ, Berkeley Heights NJ,
Sponsor: Crescendo Bioscience
Sex: All
Age: 18 - 70+
Code: NCT02832297
Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Ridgewood NJ, New York NY, Sparta NJ, Manhasset NY,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & ResponsiveNew
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer